Key result
Recent advancements in transcatheter aortic valve replacement (TAVR) include optimized prosthesis designs, enhanced delivery systems, and leaflet modification devices for treating aortic stenosis.
Why the study?
Despite recent advancements in transcatheter aortic valve replacement technology, several challenges and limitations remain.
Answers are grounded in this paper and cite their sources.
Recent advancements in TAVR technology have expanded its use to younger, lower-risk patients and those with complex anatomies, though several challenges remain.
Aortic stenosis is the most prevalent valvular disease globally. Transcatheter aortic valve replacement (TAVR) has become a well-established treatment for aortic stenosis, offering outcomes comparable to surgical aortic valve replacement (SAVR). Its use has expanded to include younger, lower-risk patients and those with more complex anatomies. Recent advancements in TAVR include the increased adoption of transfemoral access, prosthesis designs optimized for challenging anatomies, enhanced delivery systems with repositioning capabilities, and outer skirts to minimize paravalvular leaks. Despite these innovations, several challenges remain. This review highlights recent updates in transcatheter heart valve (THV) systems, leaflet modification devices, and the current limitations of TAVR.
No takes yet. Share an insight, caveat, or question.
Sheikh et al. (2025) conducted a review in Aortic stenosis. Transcatheter aortic valve replacement (TAVR) was evaluated. Recent advancements in transcatheter aortic valve replacement (TAVR) include optimized prosthesis designs, enhanced delivery systems, and leaflet modification devices for treating aortic stenosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: